CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,056 | -23.5% | 8,404 | -9.0% | 0.05% | -22.0% |
| Q2 2023 | $99,412 | +14.6% | 9,239 | +8.9% | 0.06% | +22.9% |
| Q1 2023 | $86,781 | -30.0% | 8,483 | -27.8% | 0.05% | -26.2% |
| Q4 2022 | $123,973 | +11.7% | 11,751 | +35.3% | 0.06% | +47.7% |
| Q3 2022 | $111,000 | 0.0% | 8,686 | +0.8% | 0.04% | +7.3% |
| Q2 2022 | $111,000 | +6.7% | 8,620 | -13.3% | 0.04% | -12.8% |
| Q1 2022 | $104,000 | -36.2% | 9,941 | -5.6% | 0.05% | -24.2% |
| Q4 2021 | $163,000 | +4.5% | 10,536 | +52.1% | 0.06% | -10.1% |
| Q3 2021 | $156,000 | -16.6% | 6,925 | -4.9% | 0.07% | -10.4% |
| Q2 2021 | $187,000 | – | 7,281 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |